New considerations for IGFBP-3 determination in human serum [1]

Clinica Chimica Acta

Volumn 361, Issue 1-2, 2005, Pages 211-213

  Nedić, Olgica ^a   Baričević, Ivona ^a   Golubović, Snežana ^a   Jones, David R ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCLONAL ANTIBODY; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 3 ANTIBODY; SOMATOMEDIN C; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; HUMAN; IMMUNORADIOMETRIC ASSAY; LETTER; PRIORITY JOURNAL; PROTEIN DETERMINATION; SERUM; TUMOR GROWTH; WESTERN BLOTTING;

EID: 25644452792     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.05.034     Document Type: Letter

References (5)

1. N. Mauras, and M.W. Haymond Are the metabolic effects of GH and IGF-I separable? Growth Horm IGF Res 15 2005 19 27
2. J. Frystyk Free insulin-like growth factors-measurements and relationships to growth hormone secretion and glucose homeostasis Growth Horm IGF Res 14 2004 337 375
3. S. Rinaldi, R. Kaaks, and A. Zeleniuch-Jacquotte Insulin-like growth factor-I, IGF binding protein-3 and breast cancer in young women: a comparison of risk estimates using different peptide assays Cancer Epidemiol Biomarkers Prev 14 2005 48 52
4. M.T. Ochoa, K. Fholenhag, K. Malmof, M. Sanchez-Gomez, and A. Skottner Reliability of Western ligand blot method for the simultaneous relative estimation of serum insulin-like growth factor binding proteins (IGFBPs) Arch Latinoam Nutr 47 1997 331 337
5. B.A. Booth, M. Boes, and R.S. Bar IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding and structure of fragments Endocrinol Metab 34 1996 E465 E470